Kolexia
Azulay Jean-Philippe Neurologie
Azulay Jean-Philippe
Neurologie
Hôpital La Timone
Marseille, France
256 Activités
1.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Tremblement Maladie de Huntington Atrophie Syndromes parkinsoniens Tremblement essentiel Atrophie multisystématisée Ataxie Ataxie cérébelleuse

Collaborateurs

Voir plus
Eusebio Alexandre
Eusebio Alexandre
Hôpital La Timone, Marseille, France
Witjas Tatiana
Witjas Tatiana
Hôpital La Timone, Marseille, France
Fluchere Frederique
Fluchere Frederique
Hôpital La Timone, Marseille, France
Tranchant Christine
Tranchant Christine
Hôpital Civil, Strasbourg, France

Industries

Voir plus
Abbvie
22 collaboration(s)
Dernière en 2023
Allergan
6 collaboration(s)
Dernière en 2021
UCB
6 collaboration(s)
Dernière en 2023
Medtronic
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LUMA: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Essai Clinique (Biogen)   15 mars 2024
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD): A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
Essai Clinique (PTC Therapeutics)   14 mars 2024
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Essai Clinique (CHDI Foundation, Inc.)   26 février 2024
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry   25 janvier 2024
PASADENA: A Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous RO7046015/Prasinezumab (PRX002) in Participants With Early Parkinson's Disease With a 6-Year All-Participants-on-Treatment Extension
Essai Clinique (Roche)   23 janvier 2024
Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study.
Drugs - real world outcomes   09 janvier 2024
Orthostatic hypotension: Review and expert position statement.
Revue neurologique   19 décembre 2023
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.
Scientific reports   01 décembre 2023
A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations.
Genes   29 novembre 2023
TEMPO-2: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon in Early Parkinson's Disease (TEMPO-2 Trial)
Essai Clinique (Cerevel Therapeutics, LLC)   28 novembre 2023